Real-time enrollment status for this prostate adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT06257693 |
| Recruiting Status | Recruiting |
| Condition | Prostate Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 56 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Alessa Therapeutics Inc. |
| Last Updated on CT.gov | February 27, 2026 (Feb 27, 2026) |
As of July 13, 2026: Clinical trial NCT06257693 is currently recruiting participants. This clinical trial study for prostate adenocarcinoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Alessa Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06257693 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06257693 was last updated Feb 27, 2026 (February 27, 2026). HelloStudys verifies this status automatically.